Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$2.20 USD
-0.34 (-13.39%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $2.28 +0.08 (3.64%) 6:00 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 12/5/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | 0.47 |
Last EPS Surprise | 173.44% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.95 |
Next Year | -0.85 |
EPS (TTM) | -11.84 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.00M | 1.20M | 3.77M | 5.80M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 1.00M | 1.20M | 3.77M | 5.80M |
Low Estimate | 1.00M | 1.20M | 3.77M | 5.80M |
Year ago Sales | 0.78M | 0.89M | 13.37M | 3.77M |
Year over Year Growth Est. | 28.21% | 34.83% | -71.80% | 53.85% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.35 | -2.95 | -0.85 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.35 | -0.35 | -2.95 | -0.85 |
High Estimate | -0.35 | -0.35 | -2.95 | -0.85 |
Low Estimate | -0.35 | -0.35 | -2.95 | -0.85 |
Year ago EPS | -5.20 | -1.80 | -15.20 | -2.95 |
Year over Year Growth Est. | 93.27% | 80.56% | 80.59% | 71.19% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.35 | -2.95 | -0.85 |
7 Days Ago | -0.35 | -0.35 | -2.95 | -0.85 |
30 Days Ago | -0.35 | -0.35 | -2.95 | -0.85 |
60 Days Ago | -0.35 | -0.35 | -2.95 | -0.85 |
90 Days Ago | -0.92 | -0.91 | -6.54 | -2.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.35 | -2.95 | -0.85 |
Zacks Consensus Estimate | -0.35 | -0.35 | -2.95 | -0.85 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.47 | -5.31 | -1.80 | -5.20 | NA |
Estimate | -0.64 | -4.60 | -6.20 | -5.40 | NA |
Difference | 1.11 | -0.71 | 4.40 | 0.20 | 1.25 |
Surprise | 173.44% | -15.43% | 70.97% | 3.70% | 58.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more